Fulgent Genetics, Inc. (FLGT)
16.04
+0.09
(+0.56%)
USD |
NASDAQ |
May 20, 09:53
Fulgent Genetics EPS Diluted (Quarterly) : -0.8039 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 2.241 |
| Labcorp Holdings, Inc. | 3.351 |
| Psychemedics Corp. | -- |
| Guardant Health, Inc. | -0.8538 |
| Castle Biosciences, Inc. | -0.4859 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.27M |
| Revenue (Quarterly) | 71.14M |
| Total Expenses (Quarterly) | 95.96M |
| Enterprise Value | 181.20M |
| Gross Profit Margin (Quarterly) | 27.35% |
| Profit Margin (Quarterly) | -35.53% |
| Earnings Yield | -14.93% |
| Normalized Earnings Yield | -13.09 |